Pharmaceutical Grade Research Lab

Research & Formulation Laboratory

Modern Formulas.Modern Procedures.Peptides Done Better.

Oxygen is the enemy of a modern peptide. Our vials are flushed and packed with pure argon — an inert gas denser than air, and the gold standard for protecting oxidation-sensitive drug product. A vacuum cannot do this. It is never total, it draws air inward through any breach, and it offers nothing once the first dose is drawn. An argon-packed vial holds its protection through every dose, and because gas flows outward rather than in, it helps preserve sterility across the whole life of the vial instead of only until it is opened.

The formulations and the procedures built around them exist to protect fragile molecules while they sit in the vial — and to hold potency longer once they are reconstituted.

We built the procedures

Where an established method existed, we followed it. Where one did not, we developed it — and where the equipment to do it properly was not available, we designed and built our own.

We developed the formulas

New formulations, derived from the published literature and patent record rather than inherited from what everyone else sells. Ratios, vehicles and containers chosen for a reason we can point to.

We ran the testing

Pilot batches, reconstitution trials, filtration and stability work — the unglamorous testing that finds a problem before it reaches a vial. The process is built toward pharmaceutical practice, and it changes whenever the evidence does.

We source at the top

Actives are purchased directly from established API manufacturers, never through resellers repackaging someone else's material. Every input arrives with a certificate of analysis in hand before it is touched.

The Lab

What makes this different

We are a research and formulation lab. We develop peptide formulations, do the science behind them, and build the processes those formulations need to survive contact with the real world. Here is what that actually means in practice.

Every vial is sealed under argon

An ordinary vial is filled in room air and handed to you with that air still inside. Oxygen is left sitting against the product for its entire shelf life, and every draw pulls more in behind the needle. We do not do that. Our vials go through repeated cycles of vacuum and argon backfill, so the headspace above the product is inert gas rather than air — and the closure system is chosen so none gets back in afterward. Argon is heavier than air and chemically unreactive, which is why it is used to protect oxidation-sensitive material in industries far more demanding than this one. Most testing tells you what was in a vial the day it was tested. This is about what is still there weeks later, when you actually use it.

How the argon system works

Pen cartridges, which effectively nobody offers

Almost everything in this space ships as a vial you draw from with a syringe. We formulate into pen cartridges. A pen meters the dose mechanically instead of asking you to read a plunger against a scale, so the dose you set is the dose you get. It uses a very short, very fine needle rather than a drawing needle reused against a stopper — and needle reuse is documented to leave microscopic barbs that tear rather than pierce. The cartridge stays sealed throughout: no coring, no repeated stopper punctures, no air pulled in behind each draw. It is a meaningfully better delivery system, and the reason it is rare is that it is harder to formulate and fill for.

See the cartridge system

The water is half the formulation

A perfectly formulated, argon-sealed cartridge reconstituted with oxygenated, pH-random water is not a protected product. Most bacteriostatic water is treated as a commodity diluent — sterile water plus a preservative, sitting wherever its pH happens to land, with room air over it in the vial. Ours is argon-flushed during fill and argon-packed in the vial, so no dissolved oxygen enters your cartridge at the exact moment the peptide is most vulnerable. Its starting pH is deliberately tuned to a tight window, because that is what lets a buffered cake land the final solution on target instead of wherever the batch happened to sit.

Why our water is different

Custom blends are the actual work

Combining compounds into one vial is not a marketing exercise — it is the hardest part of formulation and the part almost nobody does honestly. The constraint is compatibility, and it is a hard one: compatible pH windows, no adverse interaction between actives, no excipient that protects one component while degrading another, and verified stability of the combination rather than stability assumed from its parts. Where compounds cannot safely share a vial, they do not — and we say so, instead of combining them anyway because the marketing is cleaner. Fewer injections is a clinical goal rather than a convenience, and every blend we publish exists because the chemistry actually supported it.

Browse the custom blends

Enhanced single peptides

Not every compound needs to be a blend. A large part of what we formulate is single molecules — the ones the research is clearest on — where the differentiation is entirely in the formulation and the container rather than in novelty. Same lyoprotectant work, same buffered vehicle, same argon seal, same measured fill. For each one we publish what the research actually describes, the specification, and the solution characteristics: pH, osmolality, and how it is intended to be reconstituted.

Browse enhanced peptides

How the lab is built

Formulation work is only as good as the environment it happens in. The lab is built around controlled air, controlled surfaces, and controlled inputs — a purpose-built room with engineered airflow, gowning and personnel discipline, water generated in-house, sterile filtration, and freeze-drying under monitored conditions. Clean is not the same as endotoxin-free, and the difference is a matter of procedure rather than equipment. This is the part of the operation nobody advertises, because it is expensive to build, tedious to maintain, and completely invisible in the finished product.

Inside the lab

How we know what's in the vial

Every active arrives with a certificate of analysis in hand before it is touched — we do not buy on trust and test afterward. Measurement is held to the same standard: analytical balances verified against certified weights, dispensing held to a fraction of a percent, and fills confirmed by weight rather than assumed. Known input plus verified measurement means the contents of a finished vial are a calculated quantity, not an estimate. We test our own output, and we use outside laboratories to audit whether our procedures do what we say they do. We would rather you did not take our word for it — send our product to any lab you like, including ones we have never heard of.

Send it to any lab

Why this lab exists at all

The evidence is out there — published trials with real dosing arms, patents describing formulations in reproducible detail, pharmacokinetic and receptor binding data. Almost none of it shows up in how these compounds are actually sold. What circulates instead is a number somebody posted once, repeated until it became a standard. Trace any widely repeated protocol backward and you can usually find the exact point where a guess became a fact. Meanwhile most companies selling peptides are not making them — follow a dozen well-known brands and the supply chain collapses into a handful of sources. Every dose and ratio we use traces back to something. If we cannot trace it, we do not build on it.

Read the full story

What we formulate

We publish first-hand protocol accounts — what people actually run, and what happened, including the parts that didn't work.

Read the protocols